NCT07215533 Effects of HIIT vs. TRE on Type 2 Diabetes Risk
| NCT ID | NCT07215533 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Syracuse University |
| Condition | Obesity and Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-03-15 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-03-15 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this randomized controlled trial is to examine the effects of a 4-week high-intensity interval training (HIIT) and time-restricted eating (TRE) intervention on cardiometabolic biomarkers in adolescents and young adults.
Eligibility Criteria
Inclusion Criteria: * Adolescents (age 14-17 years old with sex- and race-specific BMI percentile ≥85th) and young adults with overweight and obesity (age 18 to 30 years old with BMI ≥25 kg/m2) Exclusion Criteria: * Chronic medical conditions: heart disease, arrhythmias, diabetes, thyroid disease, bleeding disorder, history of pulmonary disease, hypertension, hepatorenal disease, musculoskeletal disorder, neuromuscular/neurological disease, autoimmune disease, cancer, peptic ulcers, anemia, or chronic infection (HIV). * Have taken any heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti- hypertensive, endocrinologic (e.g., thyroid, insulin, etc.), emotional/psychotropic (e.g., Prednisone, Ritalin, Adderall), neuromuscular/neurological, or androgenic medications (anabolic steroids). * Have a pacemaker.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07215533 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 30 Years, studying Obesity and Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07215533 currently recruiting?
Yes, NCT07215533 is actively recruiting participants. Contact the research team at wcho02@syr.edu for enrollment information.
Where is the NCT07215533 trial being conducted?
This trial is being conducted at Syracuse, United States.
Who is sponsoring the NCT07215533 clinical trial?
NCT07215533 is sponsored by Syracuse University. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.